159 related articles for article (PubMed ID: 17168568)
21. Low-density lipoprotein receptor structure and folding.
Gent J; Braakman I
Cell Mol Life Sci; 2004 Oct; 61(19-20):2461-70. PubMed ID: 15526154
[TBL] [Abstract][Full Text] [Related]
22. Protein origami: therapeutic rescue of misfolded gene products.
Conn PM; Leaños-Miranda A; Janovick JA
Mol Interv; 2002 Sep; 2(5):308-16. PubMed ID: 14993385
[TBL] [Abstract][Full Text] [Related]
23. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
Karakoula A; Tovey SC; Brighton PJ; Willars GB
Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
[TBL] [Abstract][Full Text] [Related]
24. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
25. Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene.
Santos EL; Reis RI; Silva RG; Shimuta SI; Pecher C; Bascands JL; Schanstra JP; Oliveira L; Bader M; Paiva AC; Costa-Neto CM; Pesquero JB
Regul Pept; 2007 Jun; 141(1-3):159-67. PubMed ID: 17320985
[TBL] [Abstract][Full Text] [Related]
26. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
Schwieger I; Lautz K; Krause E; Rosenthal W; Wiesner B; Hermosilla R
Mol Pharmacol; 2008 Mar; 73(3):697-708. PubMed ID: 18048502
[TBL] [Abstract][Full Text] [Related]
27. Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor.
Leskelä TT; Markkanen PM; Alahuhta IA; Tuusa JT; Petäjä-Repo UE
Traffic; 2009 Jan; 10(1):116-29. PubMed ID: 19000170
[TBL] [Abstract][Full Text] [Related]
28. Disease-causing V(2) vasopressin receptors are retained in different compartments of the early secretory pathway.
Hermosilla R; Oueslati M; Donalies U; Schönenberger E; Krause E; Oksche A; Rosenthal W; Schülein R
Traffic; 2004 Dec; 5(12):993-1005. PubMed ID: 15522100
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of GABAB receptor exocytosis, endocytosis, and degradation.
Benke D
Adv Pharmacol; 2010; 58():93-111. PubMed ID: 20655479
[TBL] [Abstract][Full Text] [Related]
30. Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function.
Bédécarrats GY; Kaiser UB
Semin Reprod Med; 2007 Sep; 25(5):368-78. PubMed ID: 17710733
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.
Thompson MD; Cole DE; Jose PA
Methods Mol Biol; 2008; 448():77-107. PubMed ID: 18370232
[TBL] [Abstract][Full Text] [Related]
32. ER-bound steps in the biosynthesis of G protein-coupled receptors.
Nanoff C; Freissmuth M
Subcell Biochem; 2012; 63():1-21. PubMed ID: 23161130
[TBL] [Abstract][Full Text] [Related]
33. Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.
Ulloa-Aguirre A; Michael Conn P
Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):13-24. PubMed ID: 22074574
[TBL] [Abstract][Full Text] [Related]
34. Use of Kaede fusions to visualize recycling of G protein-coupled receptors.
Schmidt A; Wiesner B; Weisshart K; Schulz K; Furkert J; Lamprecht B; Rosenthal W; Schülein R
Traffic; 2009 Jan; 10(1):2-15. PubMed ID: 18939954
[TBL] [Abstract][Full Text] [Related]
35. A-kinase anchoring proteins: trafficking in G-protein-coupled receptors and the proteins that regulate receptor biology.
Malbon CC
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):573-9. PubMed ID: 17786856
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.
Maya-Núñez G; Ulloa-Aguirre A; Janovick JA; Conn PM
Subcell Biochem; 2012; 63():263-89. PubMed ID: 23161143
[TBL] [Abstract][Full Text] [Related]
37. Functioning and evolutionary significance of nutrient transceptors.
Thevelein JM; Voordeckers K
Mol Biol Evol; 2009 Nov; 26(11):2407-14. PubMed ID: 19651853
[TBL] [Abstract][Full Text] [Related]
38. Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect.
Brothers SP; Cornea A; Janovick JA; Conn PM
Mol Endocrinol; 2004 Jul; 18(7):1787-97. PubMed ID: 15105440
[TBL] [Abstract][Full Text] [Related]
39. Comparative genomics of leucine-rich repeats containing G protein-coupled receptors and their ligands.
Van Loy T; Vandersmissen HP; Van Hiel MB; Poels J; Verlinden H; Badisco L; Vassart G; Vanden Broeck J
Gen Comp Endocrinol; 2008 Jan; 155(1):14-21. PubMed ID: 17706217
[TBL] [Abstract][Full Text] [Related]
40. A point mutation in the human melanin concentrating hormone receptor 1 reveals an important domain for cellular trafficking.
Fan J; Perry SJ; Gao Y; Schwarz DA; Maki RA
Mol Endocrinol; 2005 Oct; 19(10):2579-90. PubMed ID: 15928315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
